| 摘要: |
| 目的 以查尔酮为先导化合物,设计并合成多靶标受体酪氨酸激酶抑制剂。方法 查尔酮骨架上引入苯甲酰胺片段,设计、合成了35个不含共轭双键的查尔酮衍生物。采用ADP-GloTM方法评价化合物对EGFR, KDR和FGFR1 三种肿瘤相关RTKs的抑制活性;采用MTT方法评价化合物对 MCF-7、A549、K562的细胞增殖抑制活性。结果 大部分目标化合物具有较好的RTKs抑制活性和抗肿瘤活性,部分化合物的活性接近阳性对照的水平。结论 新型查尔酮衍生物具潜在抗肿瘤活性,为抗肿瘤药物的发现奠定了基础。 |
| 关键词: 查尔酮衍生物 苯甲酰胺 受体酪氨酸激酶 抗增殖活性 肿瘤细胞 |
| DOI:10.13506/j.cnki.jpr.2020.12.002 |
| 基金项目:国家自然科学基金(No.81302641);陕西省自然科学基金(No.2018JM7071) |
|
Publication Date:December 25, 2020
|
|
| Synthesis and preliminary evaluation of multi-target RTK inhibitors |
| SHAN Yuanyuan,LIU Tingting,MA Ying,WANG Maoyi |
| (Department of Pharmacy,The First Affiliated Hospital of Xi'an Jiaotong University,Xi’an 710061,China) |
| Abstract: |
| Objective To design and synthesize novel multi-target receptor tyrosine kinase (RTK) inhibitors with chalcone as lead compound.Methods 35 chalcone derivatives were synthesized and their structures were confirmed. All the title compounds were evaluated for their enzymatic inhibition against EGFR, KDR and FGFR1 using ADP-GloTM assays. The anti-proliferative activity against MCF-7, A549, and K562 were identified by using MTT.Results Most of the title compounds exhibited potent multiple RTK inhibition and anti-proliferative activities, which was comparable to that of the positive control.Conclusion Initial studies provide a first generation of chalcone-based multi-target RTK inhibitors as anticancer agents,and are worth of further investigation. |
| Key words: Chalcone derivatives Benzamide RTK Anti-proliferative activity Cancer cell. |